Literature DB >> 11005571

HGF/SF activates glycolysis and oxidative phosphorylation in DA3 murine mammary cancer cells.

O Kaplan1, M Firon, A Vivi, G Navon, I Tsarfaty.   

Abstract

Hepatocyte growth factor/scatter factor (HGF/SF) is a paracrine growth factor which increases cellular motility and has also been implicated in tumor development and progression and in angiogenesis. Little is known about the metabolic alteration induced in cells following Met-HGF/SF signal transduction. The hypothesis that HGF/SF alters the energy metabolism of cancer cells was investigated in perfused DA3 murine mammary cancer cells by nuclear magnetic resonance (NMR) spectroscopy, oxygen and glucose consumption assays and confocal laser scanning microscopy (CLSM). 31P NMR demonstrated that HGF/SF induced remarkable alterations in phospholipid metabolites, and enhanced the rate of glucose phosphorylation (P < .05). 13C NMR measurements, using [13C1]-glucose-enriched medium, showed that HGS/SF reduced the steady state levels of glucose and elevated those of lactate (P < .05). In addition, HGF/SF treatment increased oxygen consumption from 0.58+/-0.02 to 0.71+/-0.03 micromol/hour per milligram protein (P < .05). However, it decreased CO2 levels, and attenuated pH decrease. The mechanisms of these unexpected effects were delineated by CLSM, using NAD(P)H fluorescence measurements, which showed that HGF/SF increased the oxidation of the mitochondrial NAD system. We propose that concomitant with induction of ruffling, HGF/SF enhances both the glycolytic and oxidative phosphorylation pathways of energy production.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11005571      PMCID: PMC1550289          DOI: 10.1038/sj.neo.7900103

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  55 in total

1.  The met proto-oncogene receptor and lumen formation.

Authors:  I Tsarfaty; J H Resau; S Rulong; I Keydar; D L Faletto; G F Vande Woude
Journal:  Science       Date:  1992-08-28       Impact factor: 47.728

2.  31P NMR of mammalian cells encapsulated in alginate gels utilizing a new phosphate-free perfusion medium.

Authors:  K S Narayan; E A Moress; J C Chatham; P B Barker
Journal:  NMR Biomed       Date:  1990-02       Impact factor: 4.044

3.  Toxicity and effects of epidermal growth factor on glucose metabolism of MDA-468 human breast cancer cells.

Authors:  O Kaplan; J W Jaroszewski; P J Faustino; G Zugmaier; B W Ennis; M Lippman; J S Cohen
Journal:  J Biol Chem       Date:  1990-08-15       Impact factor: 5.157

Review 4.  Cytotoxic mechanism of tumor necrosis factor-alpha.

Authors:  J W Larrick; S C Wright
Journal:  FASEB J       Date:  1990-11       Impact factor: 5.191

5.  Smooth muscle releases an epithelial cell scatter factor which binds to heparin.

Authors:  E M Rosen; I D Goldberg; B M Kacinski; T Buckholz; D W Vinter
Journal:  In Vitro Cell Dev Biol       Date:  1989-02

6.  Information from combined 1H and 31P NMR studies of cell extracts: differences in metabolism between drug-sensitive and drug-resistant MCF-7 human breast cancer cells.

Authors:  O Kaplan; P C van Zijl; J S Cohen
Journal:  Biochem Biophys Res Commun       Date:  1990-06-15       Impact factor: 3.575

7.  Effects of 2-deoxyglucose on drug-sensitive and drug-resistant human breast cancer cells: toxicity and magnetic resonance spectroscopy studies of metabolism.

Authors:  O Kaplan; G Navon; R C Lyon; P J Faustino; E J Straka; J S Cohen
Journal:  Cancer Res       Date:  1990-02-01       Impact factor: 12.701

8.  Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor.

Authors:  S Rong; M Bodescot; D Blair; J Dunn; T Nakamura; K Mizuno; M Park; A Chan; S Aaronson; G F Vande Woude
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

Review 9.  Magnetic resonance spectroscopy of tumors and potential in vivo clinical applications: a review.

Authors:  P F Daly; J S Cohen
Journal:  Cancer Res       Date:  1989-02-15       Impact factor: 12.701

10.  Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth.

Authors:  F Bussolino; M F Di Renzo; M Ziche; E Bocchietto; M Olivero; L Naldini; G Gaudino; L Tamagnone; A Coffer; P M Comoglio
Journal:  J Cell Biol       Date:  1992-11       Impact factor: 10.539

View more
  17 in total

1.  Noninvasive real-time imaging of apoptosis.

Authors:  Bharathi Laxman; Daniel E Hall; Mahaveer Swaroop Bhojani; Daniel A Hamstra; Thomas L Chenevert; Brian D Ross; Alnawaz Rehemtulla
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-10       Impact factor: 11.205

2.  HGF/SF increases tumor blood volume: a novel tool for the in vivo functional molecular imaging of Met.

Authors:  Galia Tsarfaty; Gideon Y Stein; Sharon Moshitch-Moshkovitz; Dafna W Kaufman; Brain Cao; James H Resau; George F Vande Woude; Ilan Tsarfaty
Journal:  Neoplasia       Date:  2006-05       Impact factor: 5.715

3.  In vivo direct molecular imaging of early tumorigenesis and malignant progression induced by transgenic expression of GFP-Met.

Authors:  Sharon Moshitch-Moshkovitz; Galia Tsarfaty; Dafna W Kaufman; Gideon Y Stein; Keren Shichrur; Eddy Solomon; Robert H Sigler; James H Resau; George F Vande Woude; Ilan Tsarfaty
Journal:  Neoplasia       Date:  2006-05       Impact factor: 5.715

4.  Met-HGF/SF signal transduction induces mimp, a novel mitochondrial carrier homologue, which leads to mitochondrial depolarization.

Authors:  Gil M Yerushalmi; Raya Leibowitz-Amit; Miriam Shaharabany; Ilan Tsarfaty
Journal:  Neoplasia       Date:  2002 Nov-Dec       Impact factor: 5.715

5.  MRI of mouse models for gliomas shows similarities to humans and can be used to identify mice for preclinical trials.

Authors:  Jason A Koutcher; Xiaoyi Hu; Su Xu; Terence P F Gade; Norman Leeds; Xiaohong Joe Zhou; David Zagzag; Eric C Holland
Journal:  Neoplasia       Date:  2002 Nov-Dec       Impact factor: 5.715

Review 6.  Applications of NMR spectroscopy to systems biochemistry.

Authors:  Teresa W-M Fan; Andrew N Lane
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2016-02-06       Impact factor: 9.795

7.  HGF-induced invasion by prostate tumor cells requires anterograde lysosome trafficking and activity of Na+-H+ exchangers.

Authors:  Joshua J Steffan; Brittany C Williams; Tomas Welbourne; James A Cardelli
Journal:  J Cell Sci       Date:  2010-03-09       Impact factor: 5.285

8.  mTOR-mediated dedifferentiation of the retinal pigment epithelium initiates photoreceptor degeneration in mice.

Authors:  Chen Zhao; Douglas Yasumura; Xiyan Li; Michael Matthes; Marcia Lloyd; Gregory Nielsen; Kelly Ahern; Michael Snyder; Dean Bok; Joshua L Dunaief; Matthew M LaVail; Douglas Vollrath
Journal:  J Clin Invest       Date:  2010-12-06       Impact factor: 14.808

9.  The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type.

Authors:  Mariia O Yuneva; Teresa W M Fan; Thaddeus D Allen; Richard M Higashi; Dana V Ferraris; Takashi Tsukamoto; José M Matés; Francisco J Alonso; Chunmei Wang; Youngho Seo; Xin Chen; J Michael Bishop
Journal:  Cell Metab       Date:  2012-02-08       Impact factor: 27.287

Review 10.  HGF/Met Signaling in Head and Neck Cancer: Impact on the Tumor Microenvironment.

Authors:  Stefan Hartmann; Neil E Bhola; Jennifer R Grandis
Journal:  Clin Cancer Res       Date:  2016-07-01       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.